IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
第一作者:
Thomas A,Mace
第一单位:
Divisions of Medical Oncology and Gastroenterology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
作者:
主题词
肌动蛋白类(Actins);动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 胰腺管(Carcinoma, Pancreatic Ductal);疾病模型, 动物(Disease Models, Animal);疾病恶化(Disease Progression);女(雌)性(Female);人类(Humans);白细胞介素6(Interleukin-6);Janus激酶类(Janus Kinases);L选择素(L-Selectin);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);胰腺肿瘤(Pancreatic Neoplasms);胰腺星形细胞(Pancreatic Stellate Cells);STAT转录因子类(STAT Transcription Factors);存活率(Survival Rate);Th1细胞(Th1 Cells);肿瘤微环境(Tumor Microenvironment);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1136/gutjnl-2016-311585
PMID
27797936
发布时间
2019-02-01
- 浏览9

Gut
320-332页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文